PRESENTATION
Q3 2022 — Presentation
Q3 2022PDF · 33 pages621 KB
Presentation to Investors and Analysts HSBC Holdings plc 3Q22 Results -- 1 of 33 -- Appendix 3Q22 results Our purpose, values and ambition support the execution of our strategy Opening up a world of opportunity Our purpose Our values Our strategy Our ambition To be the preferred international financial partner for our clients We value difference We succeed together We take responsibility We get it done Focus on our strengths Digitise at scale Energise for growth Transition to net zero -- 2 of 33 -- 2 Appendix 3Q22 results 3Q22 highlights 4 Adjusted costs stable vs. 9M21, on track to deliver broadly stable costs in FY22. 3Q22 costs of $7.3bn up 5% vs. a low 3Q21 base 3 3Q22 ECL charge of $1.1bn reflects developments in mainland China’s CRE market and heightened economic uncertainty and inflation in the UK; Stage 1 and 2 charges of $0.6bn, Stage 3 charges remain low at $0.4bn 1 Good set of results; reported PBT of $3.1bn, including $2.4bn impairment related to the planned disposal of our French retail business; adjusted PBT of $6.5bn, up $1.0bn (18%) vs. 3Q21 5 CET1 ratio1 of 13.4% down 0.2ppts vs. 2Q22, including c.0.3ppts impact from planned French retail disposal, intend to be in target range during 1H23 A reconciliation of reported results to adjusted results can be found on slide 13, the remainder of the presentation unless otherwise stated, is presented on an adjusted basis Figures throughout this presentation may be subject to rounding adjustments and therefore may not sum precisely to totals given in charts, tables or commentary 2 Adjusted revenue of $14.3bn, up $3.1bn (28%) vs. 3Q21; strong NII, up $2.5bn (40%) vs. 3Q21; non-NII up $0.6bn (13%) vs. 3Q21 -- 3 of 33 -- 3 Appendix 3Q22 results 3Q22 results summary $m 3Q22 3Q21 Δ NII 8,564 6,097 40% Non-NII 5,739 5,100 13% Revenue 14,303 11,197 28% ECL (1,075) 561 >(100)% Costs (7,300) (6,926) (5)% Associates 581 676 (14)% Adjusted PBT 6,509 5,508 18% Significant items and FX translation (3,362) (105) >(100)% Reported PBT 3,147 5,403 (42)% Reported earnings per share, $ 0.10 0.18 $(0.08) Impact of sig items on reported EPS, $ (0.13) (0.02) $(0.11) Reported RoTE 2 (YTD, annualised), % 9.2 9.1 0.1ppts $bn 3Q22 2Q22 Δ Customer loans 968 985 (2)% Customer deposits 1,567 1,584 (1)% Reported RWAs 828 852 (3)% CET1 ratio 1, % 13.4 13.6 (0.2)ppts TNAV per share, $ 7.13 7.48 $(0.35) Good set of 3Q22 results, reported PBT of $3.1bn; adjusted PBT of $6.5bn up $1.0bn (18%) vs. 3Q21 Revenue of $14.3bn, up $3.1bn (28%) vs. 3Q21, strong NII growth, up $2.5bn (40%) vs. 3Q21 due to higher rates; non-NII up $0.6bn (13%) vs. 3Q21, with lower fees offset by strong trading income ECL charge of $1.1bn vs. a net release of $0.6bn in 3Q21 Costs of $7.3bn, up 5% vs. 3Q21. Increased technology spend, performance-related pay accrual and inflation were partly offset by $0.6bn of cost saves Associate income down $0.1bn (14%) primarily due to non-repeat of a 3Q21 gain within BGF Significant items up, mainly $2.4bn relating to the re-classification of our French retail operations to held for sale (HFS) and $0.7bn restructuring and other related costs Customer lending down $18bn (2%) vs. 2Q22 due to $23bn of French loans moved to HFS. Excl. this impact, lending up $5bn (1%) Customer deposits down $16bn (1%) vs. 2Q22 due to $21bn of French deposits moved to HFS. Excl. this impact, deposits up $5bn (0%) CET1 ratio of 13.4% down 0.2ppts vs. 2Q22, includes negative movements of c.0.3ppts relating to planned French disposal, and 0.1ppts of fair value movements TNAV per share of $7.13, down vs. 2Q22 due to negative FX and fair value movements -- 4 of 33 -- 4 Appendix 3Q22 results Adjusted revenue performance 1,248 1,226 537 3Q21 WPB CMB GBM 95 Corporate Centre 3Q22 11,197 14,303 +28% Revenue by global business, $m Global Liquidity and Cash Management (GLCM) was renamed Global Payments Solutions (GPS) during 3Q22 WPB up $1.2bn (25%): Personal Banking up $1.4bn (51%), primarily due to higher rates and balance sheet growth Wealth down $0.2bn (9%), adverse insurance market impacts of $0.4bn and lower equity sales from muted market sentiment in Hong Kong more than offset good insurance VNB and higher Private Banking NII; continued strong franchise build with net new invested assets of $91bn since 3Q21 CMB up $1.2bn (40%), primarily GPS (up $1.1bn) from higher rates and balance sheet growth GBM up $0.5bn (16%): MSS up $0.4bn (20%), benefitting from market volatility, with a continuing strong FX performance Banking up $0.3bn (18%), as lower Capital Markets & Advisory activity was offset by GPS up $0.4bn (100%), due to higher rates and organic growth Includes $375m of adverse insurance market impacts FY21 adjusted revenue at reported FX was $50.1bn, retranslated at September YTD constant currency FX rates: $46.9bn -- 5 of 33 -- 5 Appendix 3Q22 results 2,208 2,251 2,259 2,208 2,171 157bps 119bps 126bps 119bps 135bps +22bps Net interest income and margin 3Q22 reported NII of $8.6bn was up $2.0bn (30%) vs. 3Q21, primarily due to rate rises 3Q22 adjusted NII up $2.5bn (40%) vs. 3Q21, and up $1.3bn (19%) vs. 2Q22 3Q22 reported NIM of 1.57%, up 22bps vs. 2Q22 as asset yield growth more than offset increased liability costs FY22 NII guidance has been upgraded to c.$32bn Upgrading FY23 overall revenue assumptions (on a constant currency basis): Now expect FY23 NII of at least $36bn3 vs. previous guidance of ≥$37bn due to FX translation impacts of $1.2bn, primarily sterling weakness* FY23 NII guidance assumes increased trading book funding costs (interest expense) of at least $1.3bn vs. 2Q22 guidance, with an equal and opposite increase in trading income, both booked in Corporate Centre4 , due to higher short-term rates in FY23 Our NII assumptions for 2023 are cautious at this early stage, given recent volatility in FX and interest rate markets Expect low single-digit percentage lending growth in both FY22 and FY23 Reported NIM trend Discrete quarterly reported NIM Average interest earning assets (AIEAs), $bn Reported NII, $m of which: significant items 17 8,581 4Q21 6,781 0 3Q21 (7) (2) 1Q22 (12) 6,610 2Q22 3Q22 6,997 7,454 Reported NIM progression, bps 25 2Q22 Significant items Rise in rates 1 (4) 3Q22 FX 135 157 * The $1.2bn is the difference between June month average FX and September month average FX; FY21 adjusted revenue at reported FX was $50.1bn, retranslated at September YTD constant currency FX rates: $46.9bn; FY21 adjusted costs at reported FX were $32.1bn, retranslated at September YTD constant currency FX rates: $30.0bn Trading booking funding costs can be volatile; >$1.3bn is our current planning assumptions for additional funding costs in FY23 vs. 1H22 guidance -- 6 of 33 -- 6 Appendix 3Q22 results Non-NII WPB, $m CMB, $m GBM, $m Group non-NII, $m 3Q21 2Q22 3Q22 1,412 1,225 1,268 (10)% +4% Wealth Mgmt Pers. Bnking Other 3Q21 2Q22 3Q22 850 908 911 +7% 0% GPS Other 3Q21 3Q22 2Q22 876 724 625 (29)% (14)% Capital Mkts & Advisory Other 3,117 2,864 2,783 1,983 2,607 2,956 3Q21 2Q22 3Q22 5,100 5,471 5,739 +13% +5% 330 431 127 3Q21 2Q22 3Q22 (62)% (71)% 188 95 252 2Q22 3Q21 3Q22 +34% +165% 1,476 1,802 1,811 2Q22 3Q21 3Q22 +23% 0% Down vs. 3Q21 due to insurance manufacturing market impacts; down vs. 2Q22 due to a gain on policyholder funds held on deposit Up 34%, mainly higher GBM collaboration revenue due to higher FX demand Up 23%, primarily trading income due to a strong FX performance during 3Q22 in volatile market conditions Net fees down 11% vs. 3Q21, mainly GBM and Wealth Other income up $1.0bn (49%) vs. 3Q21, good Markets performance and includes trading book funding adjustments in Corporate Centre recorded as interest expense4 Down 10%, lower Wealth in Asia, as muted equity market conditions led to lower investment distribution activity Up 7%, growth mainly in GPS (up 18% following repricing initiatives) Down 29% due to lower Capital Markets & Advisory activity; GPS fees up 8% vs. 3Q21 Net fees Net fees Net fees Other income Other income Other income Other income Net fees -- 7 of 33 -- 7 Appendix 3Q22 results (0.23) 0.20 0.26 0.18 0.43 Credit performance Adjusted ECL charge / (release) trend 3Q22 ECL net charge of $1,075m Stage 1 and Stage 2 charges of $0.6bn, of which: $0.3bn relates to our China CRE portfolio $0.2bn in respect of an uncertain UK macroeconomic outlook, taken in the UK RFB Stage 3 charges remain low at $0.4bn, of which $0.1bn relates to offshore China CRE Stage 3 loans were 1.8% of total customer loans, stable vs. 2Q22 Expect ECL charge to normalise around 30bps in FY22 We currently expect the FY23 ECL charge to be towards the top end of our through-the-cycle planning range of 30-40bps At 2Q22, a 100% weighting to the Downside 2 scenario in our IFRS 9 models would generate an additional $5.6bn of ECL. Changed forward economic guidance has increased this to $6.6bn at 3Q22 ECL charge / (release) as a % of average gross loans and advances 3Q22 ECL charge / (release) by stage, $bn ECL charge / (release) by geography, $m (561) 478 619 433 1,075 3Q22 3Q21 1Q22 4Q21 2Q22 ECL, $m Stage 1-2 Stage 3 Total Wholesale 0.5 0.3 0.8 Personal 0.1 0.1 0.2 Total 0.6 0.4 1.1 3Q22 2Q22 Hong Kong* 503 214 Mainland China 89 62 Other Asia 74 (61) UK RFB 279 124 HSBC Bank plc (15) (7) Mexico 91 140 Other 54 (39) Total 1,075 433 * Charges largely relate to offshore China CRE exposures booked on Hong Kong balance sheets Total includes an additional $0.1bn ECL charge to other assets -- 8 of 33 -- 8 Appendix 3Q22 results 7,356 6,926 6,926 Adjusted costs Operating expenses trend, $m 1,303 1,407 1,480 1,480 1,493 7,259 5,832 3Q22 7,727 3Q21 116 6,204 4Q21 1Q22 5,779 2Q22 5,807 6,926 7,312 7,300 Other Group costs UK bank levy Technology 5 3Q22 vs. 3Q21, $m 3Q22 vs. 2Q22, $m 3Q22 costs of $7.3bn, up $0.4bn (5%) vs. a low 3Q21 base. Cost saves were offset by $0.3bn higher technology spend and $0.2bn higher performance-related pay (PRP) accrual as a result of timing differences. 9M22 costs of $22.7bn, broadly stable vs. 9M21 3Q22 cost saves of $0.6bn had associated CTA of $0.7bn. Programme cost saves to date of $4.9bn had associated CTA spend of $5.3bn We expect to deliver our planned cost savings with a CTA spend between $6.5- $7bn. Expect cost savings at the high end of our $5-$5.5bn range by the end of FY22 and a further c.$1bn of cost saves expected to flow through in FY23 Continue to expect broadly stable costs in FY22*; targeting c.2% cost growth in FY233 221 320 416 Other items 3Q21 6,926 (583) Cost saves PRP Tech spend6 7,300 3Q22 +5% * FY21 adjusted costs at reported FX were $32.1bn, retranslated at September YTD constant currency FX rates $30.0bn Other items includes business and volume growth of $0.1bn, inflation of $0.1bn, litigation and other one-off items of $0.2bn ‡ Reflects the impact of retranslating the prior year results of our operations in hyperinflationary economies at current year average foreign exchange rates 50 136 7.259 2Q22 (136) Cost Saves (9) PRP Tech spend6 Other items 7.300 3Q22 +1% Includes $58m of hyperinflation ‡ 5,623 -- 9 of 33 -- 9 Appendix 3Q22 results CET1 ratio of 13.4%, down 0.2ppts vs. 2Q22 due to: Impairment related to movement of French retail operations to held-for-sale: 0.3ppts Negative after-tax OCI movements: 0.1ppts Partly offset by profits net of dividend accrual: +0.2ppts Reported RWAs of $828bn, down $23bn (3%) vs. 2Q22, primarily due to FX translation We intend to manage our CET1 ratio towards 14% in 4Q22 and intend to be within our target CET1 ratio range during 1H23 CET1 ratio target range remains at 14%–14.5% in the medium term, with the intention of managing this range down further longer term Achieved RWA savings of $120bn to date as part of our transformation programme Capital adequacy 3Q22 2Q22 3Q21 Common equity tier 1 capital, $bn 111 116 133 Reported risk-weighted assets, $bn 828 852 839 CET1 ratio, % 13.4 13.6 15.9 Leverage ratio exposure, $bn 2,415 2,484 2,965 Leverage ratio 1, % 5.4 5.5 5.2 Capital progression1 CET1 ratio, % 0.2 Impact of French HFS 7 2Q22 Profits (net of dividend accrual)8 Change in RWAs 0.0 FX translation differences Movements through OCI Other 3Q22 13.6 (0.3) (0.1) 0.0 (0.1) 13.4 115.8 851.7 110.8 CET1, $bn RWAs, $bn 828.3 (27.8) (3.7) 0.0 1.8 4.4 (1.0) (2.0) -- 10 of 33 -- 10 Appendix 3Q22 results Summary * On a constant currency basis; see slide 5 for details on NII/revenue Excluding significant items ‡ On a reported basis 4 Intend to be in our CET1 ratio target range during 1H23 2 Expect an ECL charge around 30bps in FY22; credit quality of the book remains strong, expect to be towards the top end of our 30-40bps planning range in FY23 1 Good set of results; adjusted PBT of $6.5bn, up 18% vs. 3Q21; rising rates and strong markets income offset higher investment spend and a net ECL charge 5 9M22 annualised RoTE of 10.8%; continue to target 12%+ RoTE‡ in FY23 3 FY23 overall revenue assumptions upgraded*; targeting c.2% adjusted cost growth 3 6 We expect to have a 50% dividend payout ratio for FY23 and FY24; we aim to return excess capital to shareholders where appropriate -- 11 of 33 -- Appendix -- 12 of 33 -- 12 Appendix 3Q22 results Key financial metrics Reported results, $m 3Q22 2Q22 3Q21 NII 8,581 7,454 6,610 Other Income 3,035 5,318 5,402 Revenue 11,616 12,772 12,012 ECL (1,075) (448) 659 Costs (7,975) (8,107) (7,989) Associate income 581 793 721 Profit before tax 3,147 5,010 5,403 Tax (586) 762 (1,161) Profit after tax 2,561 5,772 4,242 Profit attributable to ordinary shareholders (‘PAOS’) 1,913 5,486 3,543 Basic EPS, $ 0.10 0.28 0.18 Diluted EPS, $ 0.10 0.27 0.17 DPS (declared in respect of the period), $ — 0.09 — Net interest margin (annualised), % 1.57 1.35 1.19 Alternative performance measures, $m 3Q22 2Q22 3Q21 Adjusted NII 8,564 7,227 6,097 Adjusted other income 5,739 5,471 5,100 Adjusted revenue 14,303 12,698 11,197 Adjusted ECL (1,075) (433) 561 Adjusted costs (7,300) (7,259) (6,926) Adjusted associate income 581 769 676 Adjusted profit before tax 6,509 5,775 5,508 PAOS excl. goodwill and other intangible impairment and PVIF 2,865 5,012 3,492 Return on average tangible equity (annualised) 2, % 7.8 13.3 8.7 Return on average equity (annualised) 2, % 4.7 13.0 8.0 Adjusted net loans and advances to customers, $bn 968 985 948 Adjusted customer accounts, $bn 1,567 1,584 1,540 Adjusted cost efficiency ratio, % 51.0 57.2 61.9 ECL charge/(release) as a % of average gross loans and advances to customers (annualised) 0.43 0.18 (0.23) Reported balance sheet, $bn 3Q22 2Q22 3Q21 Total assets 2,992 2,985 2,969 Net loans and advances to customers 968 1,028 1,040 Customer accounts 1,567 1,651 1,688 Quarterly average interest-earning assets 2,171 2,208 2,208 Reported loan/deposit ratio 61.7 62.3 61.6 Total shareholders’ equity (NAV) 178 188 198 Tangible ordinary shareholders’ equity (TNAV) 141 148 158 NAV per share, $ 8.00 8.41 8.70 TNAV per share, $ 7.13 7.48 7.81 Capital, leverage and liquidity1 3Q22 2Q22 3Q21 Reported risk-weighted assets, $bn 828 852 839 CET1 ratio, % 13.4 13.6 15.9 Total capital ratio (transitional), % 18.1 18.6 21.3 Leverage ratio, % 5.4 5.5 5.2 High-quality liquid assets (liquidity value), $bn 606 657 664 Liquidity coverage ratio, % 127 134 135 Share count, m 3Q22 2Q22 3Q21 Basic number of ordinary shares outstanding 19,738 19,819 20,201 Basic number of ordinary shares outstanding and dilutive potential ordinary shares 19,857 19,949 20,296 Quarterly average basic number of ordinary shares outstanding 19,752 19,884 20,213 -- 13 of 33 -- 13 Appendix 3Q22 results Reconciliation of reported PBT and adjusted profit after tax * Primarily comprises losses associated with our RWA reduction programme $m 3Q22 2Q22 3Q21 Reported PBT (B) 3,147 5,010 5,403 Revenue Currency translation — (470) (1,000) Customer redress programmes (17) 12 — Disposal, acquisitions and investment in new businesses 2,440 288 — Fair value movements on financial instruments 232 58 64 Restructuring and other related costs* 32 11 125 Currency translation of significant items — 27 (4) ECL Currency translation — 15 (98) Operating expenses Currency translation — 287 705 Customer redress programmes (15) (10) 7 Disposals, acquisitions and investment in new businesses 9 — — Impairment of goodwill and other intangibles — 9 — Restructuring and other related costs 681 589 397 o/w: costs to achieve 676 583 390 Currency translation of significant items — (27) (46) Share of profit in associates and JVs Currency translation — (24) (45) Adjusted PBT 6,509 5,775 5,508 Tax Currency translation — 36 112 Reported tax (charge) / credit (586) 762 (1,161) Tax significant items (648) (1,935) (69) Currency translation on significant items — — 6 Adjusted profit after tax (A) 5,275 4,638 4,396 Total tax, currency translation and significant items (A-B) 2,128 (372) (1,007) -- 14 of 33 -- 14 Appendix 3Q22 results Certain items included in adjusted revenue Certain items included in adjusted revenue highlighted in management commentary, $m 3Q22 2Q22 1Q22 4Q21 3Q21 Insurance manufacturing market impacts in WPB (418) (380) (280) 125 (43) of which: Asia WPB insurance manufacturing market impacts (442) (400) (362) 88 (51) Gain on Insurance policyholder funds on deposit in WPB — 294 — — — Credit and funding valuation adjustments in GBM 3 24 (29) 38 (41) Legacy Credit in Corporate Centre (6) 23 (18) (12) (34) Valuation differences on long-term debt and associated swaps in Corporate Centre (48) (32) 5 (10) (35) Turkey hyperinflation9 (28) (113) — — — Argentina hyperinflation10 (106) (86) (69) (18) (24) Total (603) (270) (391) 123 (177) -- 15 of 33 -- 15 Appendix 3Q22 results (187) 1,438 56 15 1,076 79 370 283 429 (107) (9) 95 (426) 3,106 (3) 3Q22 adjusted revenue performance 3Q22 revenue 3Q22 vs. 3Q21 Revenue by global business, $bn 5.0 5.5 6.3 3.1 3.6 4.3 3.3 3.7 3.8 (0.1) (0.2) 14.3 3Q21 (0.1) 11.2 2Q22 3Q22 12.7 +28% CMB GBM Corporate Centre WPB o/w XVAs: $44m o/w valuation differences: $(13)m 25% 40% 16% of which: GPS Principal Investments GPS GTRF Credit and Lending Other Wealth Other $6,286m $4,309m $3,823m $(115)m $14,303m 28% $1,901m $(21)m $859m $2,209m $485m $1,899m $1,407m $518m $123m MSS WPB CMB GBM Corp. Centre Group Impact of certain items Banking $1,825m Other $(190)m Personal Banking $4,262m o/w insurance market impacts: $(375)m -- 16 of 33 -- 16 Appendix 3Q22 results Net interest margin supporting information 3Q21 4Q21 1Q22 2Q22 3Q22 % of 3Q22 Group NII % of 3Q22 Group AIEA The Hongkong and Shanghai Banking Corporation (HBAP) 1.35% 1.35% 1.39% 1.46% 1.79% 51% 45% HSBC Bank plc 0.47% 0.52% 0.55% 0.57% 0.41% 5% 21% HSBC UK Bank plc (UK RFB) 1.51% 1.48% 1.63% 1.77% 1.99% 23% 18% HSBC North America Holdings, Inc 0.90% 0.87% 0.90% 1.05% 1.16% 6% 8% Quarterly NIM by key legal entity Key rates (quarter averages), bps 7 11 20 31 164 257 9 8 12 77 219 308 10 13 45 95 162 225 2Q22 3Q21 4Q21 4Q22 QTD* 1Q22 3Q22 1M HIBOR Fed effective rate BoE Base Rate Source: Bloomberg * At 21 October 2022 1 year NII sensitivity Parallel change from July 2022 to Jun 2023 Currency USD HKD GBP EUR Other Total $m $m $m $m $m $m +25bps 109 183 356 111 399 1,158 -25bps (120) (188) (393) (104) (409) (1,214) +100bps 433 720 1,513 460 1,571 4,697 -100bps (881) (1,254) (1,677) (419) (1,723) (5,954) At 30 June 2022, using a simplified pass-through assumption of 50% 5 year NII sensitivity Parallel change from July 2022 to Jun 2027 Currency USD HKD GBP EUR Other Total $m $m $m $m $m $m +25bps 850 1,011 3,002 622 2,519 8,004 -25bps (896) (1,017) (3,081) (606) (2,585) (8,185) +100bps 3,354 4,028 12,128 2,561 9,952 32,023 -100bps (5,623) (6,617) (12,483) (2,556) (10,776) (38,055) At 30 June 2022, using a simplified pass through assumption of 50% -- 17 of 33 -- 17 Appendix 3Q22 results 3Q22 financial highlights Revenue $6.3bn 25% (3Q21: $5.0bn) ECL $(0.3)bn >(100)% (3Q21: $0.2bn) Costs $(3.6)bn (3)% (3Q21: $(3.5)bn) PBT $2.4bn 35% (3Q21: $1.8bn) RoTE 11 15.2% (2.0)ppts (9M21: 17.2%) (10)% 1,097 1,019 968 542 542 506 3Q21 2Q22 3Q22 1,639 1,561 1,474 (6)% 435 453 432 778 806 779 2Q22 3Q21 3Q22 (1)% 0% +25% +14% (380) (418) (43) 125 (280) 2,131 1,809 2,121 2,532 2,319 2,824 2,905 2,987 3,369 4,262 129 126 4Q21 3Q21 1Q22 90 2 2Q22 123 3Q22 Wealth and Personal Banking Wealth excl. market impacts Personal banking Other Balance sheet, $bn Reported Wealth Balances, $bn 3Q22 vs. 3Q21 Revenue up $1.2bn (25%). Personal banking up $1.4bn (51%) primarily from interest rate rises and global balance sheet growth. Wealth down $187m, including adverse movement in market impacts of $375m and lower investment distribution, partly offset by higher Private Banking and Insurance VNB Customer lending down $3bn (1%) due to $23bn French loans moved to held for sale (HFS). Excl this impact, up $20bn from $18bn growth in mortgages and $3bn unsecured Customer accounts up $1bn despite $21bn French deposits moved to HFS. Excl. this impact, up $22bn with growth particularly in the UK and Asia Wealth balances down $165bn (10%). NNIA of $91bn in the last 12 months, (incl. $32bn this quarter) was more than offset by lower market levels and adverse FX impacts of $221bn 3Q22 vs. 2Q22 Revenue up $763m (14%). Personal banking up $893m (27%), primarily due to rate rises. Wealth down $251m (12%), primarily due to the non-repeat of a $294m gain on policyholder funds on deposit in Insurance, partly offset by higher Private Banking NII Customer lending down $21bn (5%) due to $23bn loans moved to HFS. Excl. this impact, up $2bn, including mortgage growth of $3bn and $1bn of unsecured Customer accounts down $27bn (3%) from $21bn deposits moved to HFS and outflows in Hong Kong to investments Wealth balances down $87bn (6%). NNIA of $32bn was more than offset by lower market levels and adverse FX impacts of $83bn and a $36bn reduction in wealth deposits Insurance manufacturing market impacts 5,038 4,968 4,918 5,523 6,286 Wealth deposits12 Invested assets Customer lending Customer accounts 23 French HFS portfolio 21 Revenue performance, $m -- 18 of 33 -- 18 Appendix 3Q22 results +40% +4% +6% Commercial Banking Balance sheet, $bn 3Q21 2Q22 3Q22 315 335 334 0% 3Q21 2Q22 3Q22 444 459 460 0% Customer lending Customer accounts Revenue performance, $m GPS (formerly GLCM) Credit & Lending GTRF Markets products, Insurance and Investments and Other 823 870 952 1,304 1,899 1,392 1,452 1,392 1,427 1,407 462 477 508 519 518 439 485 3,291 1Q22 3Q21 2Q22 406 335 4Q21 306 3Q22 3,083 3,134 3,556 4,309 +21% 3Q22 financial highlights Revenue $4.3bn 40% (3Q21: $3.1bn) ECL $(0.7)bn >(100)% (3Q21: $0.2bn) Costs $(1.6)bn (2)% (3Q21: $(1.5)bn) PBT $2.1bn 17% (3Q21: $1.8bn) RoTE 11 13.7% 2.1ppts (9M21: 11.6%) 3Q22 vs. 3Q21 Revenue up $1.2bn (40%) across all products with double digit growth in all regions notably in Asia and the UK. GPS revenue up >100%, driven by higher rates, higher balances and 18% fee growth. Strong growth in Trade (up 12%) and GBM Collaboration income (up 23%) ECL up $0.9bn, reflecting build-up of provisions due to a weakening forward economic outlook and Chinese commercial real estate exposures Customer lending up $20bn (6%) with growth across all regions notably in North America, Asia and the UK with Credit & Lending (up $14bn, 6%) and Trade (up $5bn, 10%) Customer accounts up $16bn (4%) with growth notably in Asia ($13bn) and Canada ($3bn) 3Q22 vs. 2Q22 Revenue up $753m (21%) with growth across all regions notably in Asia and the UK, continued growth in GPS (up 46%), higher markets treasury allocations and collaboration income Customer lending was broadly stable with continued growth in Credit & Lending partly offset by slowing momentum in Trade Customer accounts were broadly stable -- 19 of 33 -- 19 Appendix 3Q22 results Global Banking and Markets View of adjusted revenue Adjusted RWAs13, $bn 1,839 1,728 2,229 2,256 2,209 1,542 1,556 1,559 1,699 1,825 1Q22 2Q22 (95) (70) 3,823 3Q21 (69) 4Q21 (262) (211) 3Q22 3,286 3,214 3,719 3,693 +16% +4% MSS Banking Other Revenue performance, $m $m 3Q22 ∆3Q21 MSS 2,209 20% Securities Services 525 9% Global Debt Markets 112 (27)% Global FX 1,065 49% Equities 260 (20)% Securities Financing 244 19% XVAs 3 >100% Banking 1,825 18% GTRF 185 10% GPS ( formerly GLCM) 859 100% Credit & Lending 552 (6)% Capital Markets & Advisory 179 (43)% Other 50 14% GBM Other (211) >(100)% Principal Investments (21) >(100)% Other (190) (5)% Net operating income 3,823 16% 3Q21 3Q22 2Q22 234 235 238 +2% +2% 3Q22 financial highlights Revenue $3.8bn 16% (3Q21: $3.3bn) ECL $(0.1)bn >(100)% (3Q21: $0.1bn) Costs $(2.2)bn (5)% (3Q21: $(2.1)bn) PBT $1.5bn 15% (3Q21: $1.3bn) RoTE 11 11.8% 1.7ppts (9M21: 10.1%) 3Q22 vs. 3Q21 GBM Revenue of $3.8bn up $0.5bn (16%) MSS revenue of $2.2bn up $0.4bn (20%): • Global FX and Securities Financing driven by strong trading performance, continued strong client flow and disciplined risk management • Global Debt Markets and Equities down due to lower client activity and challenging primary market conditions • Securities Services growth driven by global interest rate increases, partly offset by reduced fees from lower market levels Banking revenue of $1.8bn up $0.3bn (18%): • GPS growth reflecting higher global interest rates as well as growth in deposit balances and fee income • Capital Markets & Advisory down due to subdued market conditions 3Q22 vs. 2Q22 Revenue up $0.1bn (4%): • MSS down 2% against a strong Q2 • Banking up 7%, as rising interest rates supported strong GPS results -- 20 of 33 -- 20 Appendix 3Q22 results 3Q22 financial highlights Revenue $(115m) 45% (3Q21: $(210)m) ECL $0m (100)% (3Q21: $2m) Costs $59m (67)% (3Q21: $181m) Associates $568m (14)% (3Q21: $662m) PBT $512m (19)% (3Q21: $635m) RoTE 11 4.6% (0.8)ppts (3Q21: 5.4%) Corporate Centre Revenue performance, $m 509 536 623 648 478 93 568 70 66 (2) 3Q21 12 4Q21 1Q22 (19) 119 2 2Q22 (2) 3Q22 662 618 602 769 87 (26)% Associate income detail, $m 3Q21 4Q21 1Q22 2Q22 3Q22 Central Treasury (35) (10) 5 (32) (48) Legacy Credit (34) (12) (18) 23 (6) Other (141) (98) (222) (65) (61) Total (210) (120) (235) (74) (115) Not included in Corporate Centre revenue: Markets Treasury revenue allocated to global businesses 485 458 473 358 365 BoCom Others SABB 3Q22 vs. 2Q22 Revenue down $41m (55%), primarily due to non-recurrence of valuation gains in Legacy Credit in 2Q22 and adverse valuation differences Associates down $201m (26%), primarily due to a lower share of profits in BoCom in 2Q22 which we report one quarter in arrears 3Q22 vs. 3Q21 Revenue up $95m (45%), primarily due to FX gains on revaluation and non-recurrence of loss on disposal of legacy portfolios in the US in 3Q21 Associates down $94m (14%), primarily due to the non-repeat of a 3Q21 gain in BGF in the UK Adjusted RWAs13 , $bn 53 31 3Q21 50 32 2Q22 47 31 3Q22 83 82 78 (6)% (4)% Associates Other -- 21 of 33 -- 21 Appendix 3Q22 results Shareholders’ Equity, $bn Tangible Equity, $bn TNAV per share, $ Basic number of ordinary shares, million As at 30 June 2022 188.4 148.3 7.48 19,819 Profit attributable to: 2.4 3.2 0.16 — Ordinary shareholders 14 1.9 3.2 0.16 — Other equity holders 0.5 — — — Dividends (2.2) (1.8) (0.09) — On ordinary shares (1.8) (1.8) (0.09) — On other equity instruments (0.5) — — — FX 14 (6.3) (5.8) (0.29) — Cancellation of shares — — 0.03 (83) Actuarial gains/(losses) on defined benefit plans (0.5) (0.5) (0.02) — Cash flow hedge reserves (2.7) (2.7) (0.14) — Fair value movements through ‘Other Comprehensive Income’ (0.2) (0.2) (0.01) — Of which: changes in fair value arising from changes in own credit risk 0.8 0.8 0.04 — Of which: Debt and Equity instruments at fair value through OCI (1.0) (1.0) (0.05) — Other 14 (1.2) 0.2 0.01 2 As at 30 September 2022 177.7 140.7 7.13 19,738 Average basic number of shares outstanding during 3Q22: 19,752 3Q22 TNAV per share decreased by $0.35 to $7.13 per share, mainly due to adverse FX impact, cash flow hedge reserve movements and dividends paid during the quarter, partly offset by higher profits $7.09 on a fully diluted basis 19,857 million on a fully diluted basis 3Q22 vs. 2Q22 equity drivers -- 22 of 33 -- 22 Appendix 3Q22 results Total shareholders’ equity to CET1 capital 3Q22 2Q22 1Q22 4Q21 Total equity (per balance sheet) 185,993 196,690 204,658 206,777 Non-controlling interests (8,335) (8,308) (8,365) (8,527) Total shareholders’ equity 177,658 188,382 196,293 198,250 Additional Tier 1 (19,746) (21,691) (22,414) (22,414) Total ordinary shareholders' equity 157,912 166,691 173,879 175,836 Foreseeable dividend (3,926) (3,548) (5,197) (3,655) Share buyback — — (1,000) — Adjustment for insurance / SPE’s*,15 4 (12,881) (13,479) (13,449) Allowable NCI in CET1 4,272 4,392 4,297 4,186 CET1 before regulatory adjustments 158,262 154,654 158,500 162,918 Prudential valuation adjustment (1,334) (1,299) (1,419) (1,217) Intangible assets (11,082) (11,746) (11,899) (9,123) Deferred tax asset deduction (3,528) (3,274) (1,579) (1,520) Cash flow hedge adjustment 4,669 2,124 1,297 170 Excess of expected loss (1,992) (2,373) (2,304) (2,020) Own credit spread and debit valuation adjustment (1,589) (778) 671 1,571 Defined benefit pension fund assets (5,639) (6,638) (7,797) (7,146) Direct and indirect holdings of CET1 instruments (40) (40) (40) (40) Other regulatory adjustments to CET1 capital (including IFRS 9 transitional adjustments when relevant) (340) (235) 223 766 Threshold deductions* (26,630) (14,615) (14,206) (11,794) Regulatory adjustments (47,505) (38,874) (37,053) (30,353) CET1 capital 110,757 115,780 121,447 132,565 Allowable NCI in CET1 4 Additional Tier 1 Non-controlling interests 158,262 (8,335) Total equity Regulatory adjustments CET1 capital 4,272 (3,926) Deconsolidation of insurance / SPE’s Foreseeable dividend Total ordinary shareholders’ equity (19,746) 185,993 Total shareholders’ equity 157,912 110,757 CET1 before regulatory adjustments (47,505) 177,658 Total equity to CET1 capital, at 30 September 2022, $m Total equity to CET1 capital walk, $m * These rows include offsetting entries of $12,660m relating to the start of equity accounting for our insurance subsidiaries with effect from 3Q22 -- 23 of 33 -- 23 Appendix 3Q22 results Impacts of financial investments Hold-to-collect-and-sell (‘HTC&S’) debt portfolio, $bn As part of our interest rate hedging strategy, we hold a debt portfolio of financial investments measured at fair value through other comprehensive income (‘FVOCI’), which are classified as hold-to-collect-and-sell The increase in term market yield curves in 3Q22 drove $0.9bn of additional post-tax losses through OCI; cumulative 9M22 post-tax losses through OCI were $5.8bn (0.7ppts of CET1). Over time, these adverse movements will unwind as the instruments reach maturity, although not all instruments will necessarily be held to maturity HTC&S portfolio size down to $271bn at 3Q22 vs. $347bn at FY21 We have taken actions in 9M22 to reduce the duration risk of this portfolio and the overall capital volatility of our hedging instruments, including decreasing the amount of securities held under HTC&S (measured at FVOCI) and prospectively increased those held under to hold-to-collect (measured at amortised cost) In 9M22, yields of US Treasuries, UK Gilts, and German Bunds of maturities ranging from 6 months to 10 years experienced the following average increases, with associated post-tax losses through OCI of the HTC&S portfolio of: 1Q22: 83bps and $3.1bn; 2Q22: 70bps and $1.8bn; 3Q22: 146bps and $0.9bn* The Group continues to be positively exposed to global interest rate movements. If policy rates were to follow market expectations, higher NII is expected to offset FVOCI losses through increased profitability in approximately 4 quarters from 9M22 * Source: Bloomberg Based on a static portfolio composition 347 271 FY21 3Q22 (22)% -- 24 of 33 -- 24 Appendix 3Q22 results 3Q21 2Q22 3Q22 +2% Balance sheet – customer lending 968 315 198 197 432 435 1 334 453 1 335 201 0 948 985 (2)% Balances by global business, $bn Corporate Centre GBM CMB WPB Adjusted customer lending of $968bn, down $18bn (2%) vs. 2Q22 due to the reclassification of $23bn of French loans to held for sale (HFS). Excl. this impact, lending up $5bn (1%) WPB lending decreased by $21bn (5%) due to reclassification of French assets to held for sale. Excl. this impact, up $2bn (0)% CMB lending stable with growth in Credit & Lending partly offset by lower Trade GBM lending increased $3bn (1%), predominantly in Europe Balances by region, $bn Europe Asia MENA North America o/w: US Total o/w: Hong Kong o/w: UK Latin America $(7)bn (2)% 2 $1bn 1% $(0)bn (1)% $7bn 3% 1 $(17)bn (5)% $(3)bn (1)% $(0)bn (0)% $1bn 6% $(18)bn (2)% Growth since 2Q22 o/w: mortgages o/w: mortgages $323bn $480bn $28bn $114bn $24bn $968bn $267bn $304bn $57bn -- 25 of 33 -- 25 Appendix 3Q22 results +2% 806 1,540 0 3Q21 778 318 444 1 318 459 1 2Q22 779 460 328 3Q22 1,584 1,567 (1)% Balance sheet – customer accounts Balances by global business, $bn Adjusted customer accounts of $1,567bn, down $16bn (1%) vs. 2Q22 due to the reclassification of $21bn of French deposits to held for sale (HFS). Excl. this impact, deposits up $5bn (0%) WPB customer accounts down $27bn (3%) due to reclassification of $21bn of France balances to HFS and Hong Kong outflows into investments CMB customer accounts stable GBM customer accounts up $10bn (3%) as customers have increased average balances and liquidity Average GPS (formerly GLCM) balances down $2bn (0%) vs. 2Q22 to $767bn; up $34bn (5%) vs. 3Q21 GBM Corporate Centre CMB WPB Balances by region, $bn Europe Asia MENA North America o/w: US Total o/w: Hong Kong o/w: UK Latin America $(3)bn (3)% $(7)bn (1)% $1bn 3% $9bn 2% $(12)bn (2)% $(15)bn (3)% $1bn 1% $1bn 1% $(16)bn (1)% Growth since 2Q22 $570bn $756bn $44bn $166bn $31bn $1,567bn $470bn $528bn $98bn -- 26 of 33 -- 26 Appendix 3Q22 results Hong Kong loans and deposits US$bn % Reported net loans and advances to customers 311.9 100% Personal lending 130.6 42% o/w: Mortgages 98.0 31% o/w: Credit cards 7.9 3% o/w: Other personal lending 24.7 8% Corporate and commercial lending 161.1 52% o/w: Real estate 62.2 20% o/w: Other corporate and commercial 98.9 32% Non-bank financial institutions 20.2 6% Memo: Group HK$ denominated net loans and advances 223.7 HSBC Hong Kong balance sheet c.31% of FY21 customer loans were mortgages; Hong Kong mortgages are substantially all HK$ lending Market convention for trade facility pricing is 3-month US$ LIBOR/SOFR; HSBC Hong Kong FY21 trade market share17 of 23% Corporate lending is a mixture of revolver and term lending; market convention for HK$ corporate term lending uses 1 or 3-month HIBOR At 31 December 2021 HKMA system data16 , HK$tn Source: HKMA. Data at 31 December 2021 US$bn Reported customer accounts 549.4 Memo: Group HK$ denominated deposits 318.7 System loans to customers System deposits HK$ 41% 59% By type 7% 16% 77% By currency Other 10.9 10.9 Trade financing 17 Mortgages Other Other 49% 37% 15% 15.2 By currency US$ HK$ -- 27 of 33 -- 27 Appendix 3Q22 results 6.344 1.570 By booking centre Hong Kong Mainland China RoW Total Loans and advances to customers18 9,773 6,488 441 16,702 Guarantees issued and others18 1,961 1,026 94 3,081 Total 11,734 7,514 535 19,783 By credit quality Strong 2,095 2,117 145 4,357 Good 2,429 2,898 58 5,385 Satisfactory 3,104 2,272 175 5,551 Sub-standard 1,946 95 157 2,198 Credit impaired 2,160 132 — 2,292 Total 11,734 7,514 535 19,783 Allowance for ECL (884) (103) (3) (990) Mainland China commercial real estate update 30% 18% 23% 21% 29% 26% 17% 4% 18% 14% 1H22 FY21 Good Strong Satisfactory Sub-Standard Credit Impaired Hong Kong booked exposure, distribution by credit quality Mainland China CRE exposures at 30 June 2022, $m We report our detailed exposure information at the half year and full year Real Estate business to mainland China is highly selective, focused on top tier developers with project lending concentrated in Tier 1 cities and Tier 2 cities. However, the Chinese CRE market is being impacted by the structural and policy changes that are taking place As at 30 September 2022, the ECL allowance against the offshore portfolio is $1.3bn. An additional charge of $0.4bn was taken during 3Q22 as a result of CRR downgrades, FEG deterioration and increased PD assumptions in CRE overlays -- 28 of 33 -- 28 Appendix 3Q22 results HSBC Bank Canada financial information 9M22 FY21 NII 1,155 1,226 Non-NII 679 989 Revenue 1,834 2,215 ECL (82) 45 Costs (964) (1,308) PBT 788 952 Tax (210) (235) Profit attributable to shareholder 578 717 Reported return on average common shareholder’s equity, % 14.5 11.7 Reported profit and loss account, CADm Selected balance sheet information, CADm 3Q22 FY21 Total assets 134,047 119,853 o/w: Loans and advances to customers 75,672 68,699 o/w: Goodwill and intangible assets 196 181 Total liabilities 128,311 112,977 o/w: Customer accounts 81,500 73,626 Total shareholder’s equity 5,736 6,876 o/w: Preferred shares 1,100 1,100 o/w: Tangible equity 4,440 5,595 Selected capital measures 3Q22 FY21 CET1 capital, CADm 4,919 5,590 Reported RWAs, CADm 44,481 39,836 CET1 ratio 19, % 11.1 14.0 Tier 1 ratio, % 13.5 16.8 Reported revenue and lending by global business, CADm 39% 49% 48% 45% Revenue at 9M22 75,672 1% 12% 6% 0% 1,834 Lending WPB CMB Corporate Centre GBM In 1H22 HSBC Canada paid CAD313m of dividends At 30 September 2022 -- 29 of 33 -- 29 Appendix 3Q22 results Glossary AIEA Average interest earning assets AT1 Additional Tier 1 BGF Business Growth Fund, an associate of HSBC BoCom Bank of Communications Co. Limited, an associate of HSBC Bps Basis points. One basis point is equal to one-hundredth of a percentage point CET1 Common Equity Tier 1 Corporate Centre Corporate Centre comprises Central Treasury, our legacy businesses, interests in our associates and joint ventures and central stewardship costs CMB Commercial Banking, a global business CRE Commercial Real Estate CRR Customer risk rating CTA Costs to achieve C&L Credit & Lending DPS Dividend per share ECL Expected credit losses. In the income statement, ECL is recorded as a change in expected credit losses and other credit impairment charges. In the balance sheet, ECL is recorded as an allowance for financial instruments to which only the impairment requirements in IFRS 9 are applied EPS Earnings per share FEG Forward economic guidance FVOCI Fair value through other comprehensive income GBM Global Banking and Markets, a global business GPS Global Payments Solutions (formerly GLCM: Global Liquidity and Cash Management) Group HSBC Holdings plc and its subsidiary undertakings GTRF Global Trade and Receivables Finance HFS Held for sale HIBOR Hong Kong Interbank Offered Rate HKD Hong Kong Dollar IFRS International Financial Reporting Standard Legacy credit A portfolio of assets including securities investment conduits, asset-backed securities, trading portfolios, credit correlation portfolios and derivative transactions entered into directly with monoline insurers MENA Middle East and North Africa MSS Markets and Securities Services NAV Net asset value NCI Non-controlling interests NIM Net interest margin NNIA Net new invested assets OCI Other Comprehensive Income PBT Profit before tax PD Probability of default Ppt Percentage points PRP Performance related pay PVIF Present value of in-force insurance contracts SABB The Saudi British Bank, an associate of HSBC SPE Special-purpose entity RoTE Return on average tangible equity RWA Risk-weighted asset TNAV Tangible net asset value UK RFB HSBC UK, the UK ring-fenced bank, established July 2018 as part of ring fenced bank legislation VNB Value of new business written WPB Wealth and Personal Banking, a global business XVAs Credit and Funding Valuation Adjustments -- 30 of 33 -- 30 Appendix 3Q22 results Footnotes 1. Unless otherwise stated, regulatory capital ratios and requirements are based on the transitional arrangements of the Capital Requirements Regulation in force at the time. These include the regulatory transitional arrangements for IFRS 9 ‘Financial Instruments’. The leverage ratio is calculated using the end point definition of capital and the IFRS 9 regulatory transitional arrangements, in line with the UK leverage rules that were implemented on 1 January 2022, and excludes central bank claims. Comparatives for 2021 are reported based on the disclosure rules in force at that time, and include claims on central banks. References to EU regulations and directives (including technical standards) should, as applicable, be read as references to the UK’s version of such regulation and/or directive, as onshored into UK law under the European Union (Withdrawal) Act 2018, and subsequently amended under UK law 2. Reported RoTE is computed by adjusting annualised reported results for PVIF and for impairment of goodwill and other intangible assets (net of tax), divided by average reported equity adjusted for goodwill, intangibles and PVIF for the period 3. On an IFRS 4 basis 4. Corporate Centre includes an adjustment to reverse an accounting asymmetry relating to the cost of internally sourced funding of our trading activities, which is recorded as an expense within net trading income in the relevant global business. The adjustment moves this funding cost out of net trading income and into net interest income as an interest expense, reflecting the substance of the accounting treatment for the consolidated Group. This elimination has nil impact on Corporate Centre revenue 5. Technology costs in operating expenses trends include transformation saves and are presented on a net basis 6. Technology cost increases in quarterly walks are presented on a gross basis (excl. saves) 7. Impact of planned French disposal includes post-threshold impacts 8. Regulatory profits, net of regulatory dividend accrual for the purposes of capital calculations. In the 9 months to 30 September 2022, we accrued $5.7bn after excluding the impact of the deferred tax asset created in 2Q22 and loss on reclassification of French retail operations to held for sale; equivalent to 28¢ per voting share 9. From 1 June 2022, Turkey was deemed a hyperinflationary economy for accounting purposes 10. From 1st July 2018, Argentina was deemed a hyperinflationary economy for accounting purposes 11. YTD, annualised. RoTE by Global Business excludes significant items. RoTE methodology annualises Profits Attributable to Shareholders, including ECL, in order to provide a returns metric. RoTE by Global Business considers AT1 Coupons on an accruals basis, vs. Reported RoTE where it is treated on a cash basis 12. Wealth deposits include Premier, Jade and Global Private Banking deposits, which include Prestige deposits in Hang Seng Bank, and form part of the total WPB customer accounts balance 13. A reconciliation of reported RWAs to adjusted RWAs can be found in the ‘HSBC Holdings plc 3Q 2022 Datapack’ 14. Differences between shareholders’ equity and tangible equity drivers primarily reflect AT1 capital, goodwill and other intangibles and PVIF. ‘Profit Attributable to Ordinary shareholders’ differences primarily include goodwill and other intangibles impairment, PVIF movements and amortisation expense. ‘FX’ differences primarily include FX on goodwill and intangibles. ‘Other’ differences primarily include intangible additions and redemption of securities 15. A revised approach to insurance-related adjustments has been effective from 30 September 2022. This has no impact on overall CET1 capital 16. System refers to authorised institutions under the supervision of the HKMA 17. Trade financing lending is comprised of: loans to finance imports to and exports and re-exports from Hong Kong; loans to finance merchandising trade not touching Hong Kong; and, acceptance and bills of exchange. Source: HKMA at 31 December 2021; Hong Kong market share includes HASE 18. Mainland China reported Real Estate exposures comprises exposures booked in mainland China and offshore where the ultimate parent is based in mainland China, and all exposures booked on mainland China balance sheets; Commercial Real Estate refers to lending that focuses on commercial development and investment in real estate and covers commercial, residential and industrial assets; Real Estate for Self Use refers to lending to a corporate or financial entity for the purchase or financing of a property which supports overall operations of a business i.e. a warehouse for an e- commerce firm 19. The common equity tier 1 and tier 1 ratios are calculated as the respective capital base divided by risk-weighted assets, in accordance with CAR Guideline issued by OSFI -- 31 of 33 -- 31 Appendix 3Q22 results Disclaimer Important notice The information, statements and opinions set out in this presentation and accompanying discussion (“this Presentation”) are for informational and reference purposes only and do not constitute a public offer for the purposes of any applicable law or an offer to sell or solicitation of any offer to purchase any securities or other financial instruments or any advice or recommendation in respect of such securities or other financial instruments. This Presentation, which does not purport to be comprehensive nor render any form of legal, tax, investment, accounting, financial or other advice, has been provided by HSBC Holdings plc (together with its consolidated subsidiaries, the “Group”) and has not been independently verified by any person. You should consult your own advisers as to legal, tax investment, accounting, financial or other related matters concerning any investment in any securities. No responsibility, liability or obligation (whether in tort, contract or otherwise) is accepted by the Group or any member of the Group or any of their affiliates or any of its or their officers, employees, agents or advisers (each an “Identified Person”) as to or in relation to this Presentation (including the accuracy, completeness or sufficiency thereof) or any other written or oral information made available or any errors contained therein or omissions therefrom, and any such liability is expressly disclaimed. No representations or warranties, express or implied, are given by any Identified Person as to, and no reliance should be placed on, the accuracy or completeness of any information contained in this Presentation, any other written or oral information provided in connection therewith or any data which such information generates. No Identified Person undertakes, or is under any obligation, to provide the recipient with access to any additional information, to update, revise or supplement this Presentation or any additional information or to remedy any inaccuracies in or omissions from this Presentation. Past performance is not necessarily indicative of future results. Differences between past performance and actual results may be material and adverse. Forward-looking statements This Presentation may contain projections, estimates, forecasts, targets, opinions, prospects, results, returns and forward-looking statements with respect to the financial condition, results of operations, capital position, strategy and business of the Group which can be identified by the use of forward-looking terminology such as “may”, “will”, “should”, “expect”, “anticipate”, “project”, “plan”, “estimate”, “seek”, “intend”, “target”, “believe”, "potential" and "reasonably possible" or the negatives thereof or other variations thereon or comparable terminology (together, “forward-looking statements”), including the strategic priorities and any financial, investment and capital targets and any ESG related targets, commitments and ambitions described herein. Any such forward-looking statements are not a reliable indicator of future performance, as they may involve significant stated or implied assumptions and subjective judgements which may or may not prove to be correct. There can be no assurance that any of the matters set out in forward-looking statements are attainable, will actually occur or will be realised or are complete or accurate. The assumptions and judgments may prove to be incorrect and involve known and unknown risks, uncertainties, contingencies and other important factors, many of which are outside the control of the Group. Actual achievements, results, performance or other future events or conditions may differ materially from those stated, implied and/or reflected in any forward-looking statements due to a variety of risks, uncertainties and other factors (including without limitation those which are referable to general market or economic conditions, regulatory changes, geopolitical tensions such as the Russia-Ukraine war, the impact of the Covid-19 pandemic or as a result of data limitations and changes in applicable methodologies in relation to ESG related matters). Any such forward-looking statements are based on the beliefs, expectations and opinions of the Group at the date the statements are made, and the Group does not assume, and hereby disclaims, any obligation or duty to update, revise or supplement them if circumstances or management’s beliefs, expectations or opinions should change. For these reasons, recipients should not place reliance on, and are cautioned about relying on, any forward-looking statements. No representations or warranties, expressed or implied, are given by or on behalf of the Group as to the achievement or reasonableness of any projections, estimates, forecasts, targets, commitments, ambitions, prospects or returns contained herein. Additional detailed information concerning important factors that could cause actual results to differ materially from this Presentation is available in our Annual Report and Accounts for the fiscal year ended 31 December 2021 filed with the Securities and Exchange Commission (the “SEC”) on Form 20-F on 23 February 2022 (the “2021 Form 20-F”), our 1Q 2022 Earning Release furnished to the SEC on Form 6-K on 26 April 2022 (the “1Q 2022 Earnings Release”), our Interim Financial Report for the six months ended 30 June 2022, furnished to the SEC on Form 6-K on 1 August 2022 (the “2022 Interim Report”) and our 3Q 2022 Earnings Release, which we expect to furnish to the SEC on Form 6-K on 25 October 2022 (the “3Q 2022 Earnings Release”). Alternative Performance Measures This Presentation contains non-IFRS measures used by management internally that constitute alternative performance measures under European Securities and Markets Authority guidance and non-GAAP financial measures defined in and presented in accordance with SEC rules and regulations (“Alternative Performance Measures”). The primary Alternative Performance Measures we use are presented on an “adjusted performance” basis which is computed by adjusting reported results for the period-on-period effects of foreign currency translation differences and significant items which distort period-on-period comparisons. Significant items are those items which management and investors would ordinarily identify and consider separately when assessing performance in order to better understand the underlying trends in the business. Reconciliations between Alternative Performance Measures and the most directly comparable measures under IFRS are provided in our 2021 Form 20-F, our 1Q 2022 Earnings Release, our 2022 Interim Report and our 3Q 2022 Earnings Release, when filed, each of which are available at www.hsbc.com. Information in this Presentation was prepared as at 25 October 2022. -- 32 of 33 -- -- 33 of 33 --